Lan Airlines Stock To Go Ex-dividend Tomorrow (LFL)

NEW YORK ( TheStreet) -- The ex-dividend date for Lan Airlines (NYSE: LFL) is tomorrow, May 9, 2012. Owners of shares as of market close today will be eligible for a dividend of 4 cents per share. At a price of $28.05 as of 9:30 a.m. ET, the dividend yield is 1.1%.

The average volume for Lan Airlines has been 243,200 shares per day over the past 30 days. Lan Airlines has a market cap of $9.48 billion and is part of the services sector and transportation industry. Shares are up 21.1% year to date as of the close of trading on Monday.

Lan Airlines S.A., together with its subsidiaries, provides passenger and cargo air transportation services. The company offers air cargo transportation services to other international air carriers, freight-forwarding companies, export oriented companies, and individual consumers. The company has a P/E ratio of 29.6, equal to the average transportation industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Lan Airlines as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full Lan Airlines Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus